SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

ASML Sees Fourth-Quarter Sales of EUR14.2B to EUR15.2B

ASML
SquawkNews Desk 1 updates Updated Oct 14, 2026, 05:05 AM UTC

Story updates

05:05:54 AM UTC
SquawkNews
ASML EURONEXT:ASML on Wednesday forecast fourth-quarter sales above analyst expectations, as AI-driven demand for its chipmaking equipment remains strong, and narrowed its 2026 outlook.The Dutch company guided for fourth-quarter net sales of €14.2 billion to €15.2 billion ($15.9 billion to $17.0 bi…

Related stories

Sanofi Raises 2026 Outlook Again After Beating Profit and Revenue Forecasts Sanofi exceeded profit and revenue forecasts and raised its 2026 projections again. M impact | EARNINGS | Oct 30, 2026, 05:44 PM UTC Regeneron Shares Rise 11.5% After Third-Quarter Revenue and EPS Increase Regeneron reported third-quarter 2026 revenue of $5.1 billion, up 36%, and non-GAAP diluted EPS of $20.07, up 70%. H impact | EARNINGS | Oct 30, 2026, 05:24 PM UTC Exxon Mobil, Chevron Profits Top Expectations as Refining Margins Surge Exxon Mobil and Chevron reported profits above expectations as refining margins surged during the war. Exxon Mobil’s third-quarter refining earnings exceeded its upstream earnings; M impact | EARNINGS | Oct 30, 2026, 05:22 PM UTC Exxon Mobil and Chevron Profits Beat Expectations as Refining Margins Surge Exxon Mobil and Chevron reported profits above expectations, while refining margins surged during the war. Exxon Mobil’s third-quarter refining earnings exceeded its upstream earni M impact | EARNINGS | Oct 30, 2026, 05:22 PM UTC FTSE 100 Outperforms Led by AstraZeneca The FTSE 100 was little changed on Friday, outperforming other European markets as strong results from AstraZeneca and BP offset losses in banking and mining stocks. AstraZeneca ga H impact | EARNINGS | Oct 30, 2026, 04:53 PM UTC Pemex Narrows Losses as Revenue Rises on Higher Domestic Sales M impact | EARNINGS | Oct 30, 2026, 04:51 PM UTC